Human SLAM/CD150 Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF164
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Ala21-Pro237
Accession # Q13291
Specificity
Clonality
Host
Isotype
Applications for Human SLAM/CD150 Biotinylated Antibody
Western Blot
Sample: Recombinant Human SLAM/CD150
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: SLAM/CD150
SLAM (also IPO-3 and CD150) is a 70‑80 kDa member of the CD2 family of molecules. It is a costimulatory receptor that mediates T cell activation via SAP. SLAM is found on B cells, dendritic cells, macrophages, stem cells and Th1 T cells. SLAM engages in homophilic interactions. Mature human SLAM is 315 amino acids (aa) in length. It is a type I transmembrane glycoprotein whose extracellular domain contains one V-type and one C2-type Ig-like domain (aa 21‑237). There is a 77 aa SH2‑binding cytoplasmic domain. Four potential splice variants are suggested. One shows a deletion of aa 234‑263 (potentially soluble), while three others show aa substitutions; i.e.‑a ten aa substitution for aa 289‑335, a six aa substitution for aa 264‑335 and a 20 aa substitution for aa 125‑335 (potentially soluble). Over aa 1‑236, human SLAM shares 60% aa identity with mouse SLAM.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional SLAM/CD150 Products
Product Documents for Human SLAM/CD150 Biotinylated Antibody
Product Specific Notices for Human SLAM/CD150 Biotinylated Antibody
For research use only